![]() |
Volumn 58, Issue 2, 2001, Pages 121-131
|
The cost of hepatitis C and the cost-effectiveness of its prevention
|
Author keywords
Cost if illness; Cost effectiveness; Hepatitis C; Prevention; Priority setting
|
Indexed keywords
ALPHA INTERFERON;
ABSENTEEISM;
ARTICLE;
ASCITES;
BLEEDING;
COST BENEFIT ANALYSIS;
DISEASE COURSE;
DISEASE TRANSMISSION;
DRUG ABUSE;
HEALTH CARE COST;
HEPATIC ENCEPHALOPATHY;
HEPATITIS C;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER FAILURE;
LIVER TRANSPLANTATION;
METHADONE TREATMENT;
MORBIDITY;
MORTALITY;
PREVENTIVE MEDICINE;
PUBLIC HEALTH;
SEPTICEMIA;
TERMINAL CARE;
AUSTRALIA;
BLOOD-BORNE PATHOGENS;
COST OF ILLNESS;
COST SAVINGS;
COST-BENEFIT ANALYSIS;
HEALTH CARE COSTS;
HEPATITIS C;
HUMANS;
INCIDENCE;
PREVENTIVE HEALTH SERVICES;
PUBLIC HEALTH;
|
EID: 0034846409
PISSN: 01688510
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-8510(01)00159-2 Document Type: Article |
Times cited : (16)
|
References (26)
|